Oliver S. Eng

Biography

Oliver Eng, MD, FACS, FSSO, is a surgical oncologist and an Associate Professor in the Division of Surgical Oncology at the University of California, Irvine, where he serves as Deputy Associate Director for Clinical Science at the Chao Family Comprehensive Cancer Center and Program Director of the Complex General Surgical Oncology Fellowship. He is a double board-certified surgeon and surgical oncologist who focuses on the treatment of peritoneal metastases and in complex cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Dr. Eng has co-authored numerous peer-reviewed publications and has received extramural funding for his research, which centers on better understanding the molecular and immunologic characteristics of peritoneal tumors. His research aims to develop innovative therapies for metastatic disease and optimize outcomes and care in cancer patients. He is a principal investigator or co-investigator on multiple clinical trials and serves on the editorial board for a variety of scientific journals. Dr. Eng has been appointed to lead a number of national committees, and is currently a Director on the American Board of Surgery Complex General Surgical Oncology Board.

Distinctions

• Fellow, Society of Surgical Oncology
• Fellow, American College of Surgeons
• Member, Society of University Surgeons
• Alpha Omega Alpha Honor Medical Society
• Faculty Excellence in Teaching Award, University of Chicago Department of Surgery
• 40 Under 40 in Cancer Award, The Lynx Group